Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.
The annual meeting of shareholders will be held:
Tuesday, May 9th, 2017, 8:30 a.m.
500 Boylston Street
Boston, Massachusetts 02116
Before you vote, you should carefully review our 2017 Proxy Statement, Form 10-K for fiscal year 2016, 2016 Annual Report, and related materials that were mailed on or around March 30, 2017, to shareholders of record as of March 13, 2017. For your convenience, these materials may be viewed by selecting the links below:
To view the Proxy Statement or Form 10-K, you will need Adobe Acrobat; click here for detailed download instructions.